DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, ...
Genetic tests for cancer can run thousands of dollars, but Color Genomics plans to change that: it's offering testing for the cancer risk variants BRCA1 and BRCA2 — as well as 17 others — for $249, ...
When a patient has an inherited cancer-associated gene, it is desirable — but not easy — to have other family members tested. In the United States, the difficulty primarily stems from privacy ...
Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to ...
A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can ...
The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results